News and Events
Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

Stay informed about RECOVER’s Long COVID research by reading the latest news and participating in upcoming events.

In 2026 so far, RECOVER has published new research findings across nearly all its different studies and will soon be enrolling participants for the next phases of the adult observational study and clinical trials.
During 2 webinars, RECOVER researchers and leaders will discuss its clinical trial programs—RECOVER-CT and RECOVER-TLC, including clinical trial results to date and what it means to take part in a Long COVID clinical trial.
NIH and FNIH leaders will provide an overview of the clinical trial process and updates on the status of RECOVER-TLC.
Findings from this RECOVER pathobiology study may guide future efforts to treat Long COVID-related thinking problems and fatigue.
Throughout this phase, RECOVER will continue to collect information from about 5,000 people for 2 years to build a deeper understanding of how Long COVID affects people over time.
ISCORE, a RECOVER hub spanning 10 states and Puerto Rico, is bringing Long COVID studies to communities often underfunded in research, drawing on decades of HIV experience to tackle another new infectious disease.
RECOVER scientists, study participants, and Representatives are working together to make new discoveries about Long COVID and how to diagnose, prevent, and treat its symptoms.
As RECOVER’s adult observational study moves to the next phase, researchers continue to explore the various causes of common Long COVID symptoms, such as difficulty breathing.